filmov
tv
A Conversation with MPN Specialists: A Summary of Clinical Trials, Drugs, and What They Do
![preview_player](https://i.ytimg.com/vi/Cu3HMwzaR_E/maxresdefault.jpg)
Показать описание
MPN Advocacy & Education International spoke with Dr. Ruben Mesa, UT Health San Antonio, MD Anderson Cancer Center, and Dr. Naveen Pemmaraju, MD Anderson Cancer Center, about what clinical trials are happening and what the future may hold for MPNs.
A Conversation with an MPN Specialist: Essential Thrombocythemia
A Conversation with an MPN Specialist: Questions You Should Be Asking Your Hematologists
A Conversation with an MPN Specialist: From Diagnosis to Current Treatment Options
A Conversation with an MPN Specialist: Polycythemia Vera
Conversation with MPN Specialists: Ask All of Your Questions
A Conversation with an MPN Specialist: Myelofibrosis
A Conversation with an MPN Specialist: Symptom Management and Lifestyle Changes
A Conversation with an MPN Specialist: Old and New JAK Inhibitors
Conversation with an MPN Specialist: New Combinations and Novel Approaches in the Future of MPNs
Conversation with an MPN Specialist: Everything You Should Know About Clinical Trials
A Conversation with MPN Specialists: Pediatric & Young Adults with MPNs
A Conversation with an MPN Specialist: Addressing MPNs in India
A Conversation with an MPN Specialist: Financial Toxicity and Value-Based Care
A Conversation with MPN Specialists: A Summary of Clinical Trials, Drugs, and What They Do
Conversation with MPN Specialists
A Conversation with an MPN Specialist: Interferon: Why and How it Works in MPN Patients
A Conversation with an MPN Specialist: What You Should Know About JAK Inhibitors/Non-JAK Inhibitors
A Conversation with an MPN Specialist: MPN Symptom Management
A Conversation with an MPN Specialist: Focusing on Myelofibrosis
Conversation with MPN Specialists- Focus on ET/PV
A Conversation with MPN Specialists: Everything You Need to Know About Transplants
Conversation with MPN Specialists: MPN Symptom Burden Management
Conversation with MPN Specialists: Focus on Myelofibrosis
Conversation with MPN Specialists - #2
Комментарии